General

Heidelberg Pharma offers services for the pre-clinical development of anti-cancer and anti-inflammatory drugs to the pharmaceutical and biotech industry.

Our infrastructure includes laboratories for in vivo pharmacology, bioanalytics, molecular biology, and chemistry. Within the development process, we focus on lead optimization and pre-clinical drug profiling. During this procedure, our expertise in bioanalytical analysis, hand-in-hand with our in vitro and in vivo pharmacology capabilities, assures optimum results in form of qualified data, referenced against clinical standards, creative solutions and accurate reporting.

We offer not only a wide range of validated and routinely used models and techniques. Your compound is investigated using a more exploratory approach, as our flexibility permits customized experimental designs and the development and validation of new models. As a team, we are small enough to be flexible, but large enough to be efficient, so that all service programs can be executed in a timely manner, at attractive terms. You are warmly invited to contact us for a modular approach or an integrated concept, corresponding to your needs.